Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-Naïve and CYP17 Inhibitor-Naïve Patients: Follow-Up From the ARADES and ARAFOR Trials

European Urology Focus- Netherlands

doi 10.1016/j.euf.2017.01.015

Full Text

Abstract

Available in

Categories

Urology

Date

Authors

Publisher

Elsevier BV


Related search